Drugelių pieva - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 5,455 | 2,587 | 9,128 | 18,837 | 22,157 | 29,174 | 34,807 | 27,145 |
| Profit before tax | -3,599 | 443 | 1,532 | 4,450 | -323 | 122 | 429 | -3,105 |
| Net profit | -3,599 | 443 | 1,532 | 4,308 | -323 | 115 | 409 | -3,105 |
| Equity | 10 | 466 | 1,998 | 6,305 | 5,982 | 6,097 | 6,506 | 3,401 |
| Liabilities | - | 81 | 766 | 199 | 1,100 | 4,770 | 122 | 79 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 10 | 547 | 2,764 | 6,504 | 7,082 | 10,867 | 6,444 | 3,415 |
| Total assets | 10 | 547 | 2,764 | 6,504 | 7,082 | 10,867 | 6,444 | 3,415 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 11 | 18 | 52 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +9.1% | -52.6% | +252.8% | +106.4% | +17.6% | +31.7% | +19.3% | -22.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -35990.0% | 81.0% | 55.4% | 66.2% | -4.6% | 1.1% | 6.3% | -90.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -35990.0% | 95.1% | 76.7% | 68.3% | -5.4% | 1.9% | 6.3% | -91.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -66.0% | 17.1% | 16.8% | 22.9% | -1.5% | 0.4% | 1.2% | -11.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -66.0% | 17.1% | 16.8% | 23.6% | -1.5% | 0.4% | 1.2% | -11.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.2 | 0.4 | 0.0 | 0.2 | 0.8 | 0.0 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Drugelių pieva - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-06-28 | 2023-12-31 | 1833.04 |
| 2022-07-01 | 2022-07-31 | 14.95 |
Drugelių pieva - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Drugelių pieva is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-07-14 | 2026-09-02 | 0.54 |
| 2026-07-03 | 2026-07-13 | 344.88 |
| 2026-02-21 | 2026-07-02 | 0.76 |
| 2025-06-19 | 2026-02-03 | 0.76 |
| 2025-02-05 | 2025-02-05 | 17.65 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Drugeliu pieva, MB (code 304720297) is a Small partnership engaged in Business and other management consultancy activities. In 2025, its revenue was €27.1K, down 22.0% year on year and 7.0% below the 2023 level. The company moved from modest profit in 2023 and 2024 to a net loss of €3.1K in 2025, with a profit margin of -11.4%. Over the three-year period, revenue rose from €29.2K in 2023 to €34.8K in 2024, then weakened in 2025, while net profit declined from €115 to €409 before turning negative. The balance sheet also contracted materially: total assets fell from €10.9K in 2023 to €6.4K in 2024 and €3.4K in 2025, matched by a decline in equity from €6.1K to €3.4K. Liabilities remained low at €79 in 2025. Financial structure in 2025 was equity-heavy, with an equity ratio of 99.6% and debt-to-equity of 0.02, while asset turnover was 7.95x. Return on equity and return on assets were sharply negative in the latest year.